Exercise and liraglutide for type 2 diabetes
Treatments studied
This study tests if combining exercise with a drug called liraglutide improves blood vessel health and insulin sensitivity in people with type 2 diabetes. It looks at whether these treatments work better together or alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 60 years old.
- You need to have type 2 diabetes with a recent A1C of 8.5% or less.
- You cannot be taking insulin.
- You should not have any major heart, lung, liver, kidney, or blood vessel disease.
- You must be willing to follow a stable medication plan for at least 4 months.
- You cannot be a current smoker or have smoked in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether doing exercise and a GLP-1 medicine (liraglutide or similar) can improve how your body uses insulin and how blood flows to your muscles. It is aimed at adults with metabolic syndrome who do not already have diabetes.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
This study tests whether two different treatment strategies can improve the function of the tiny blood vessels in people with type 1 diabetes. It aims to find a way to prevent or reduce diabetes-related complications.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
This study looks at how tiny particles called extracellular vesicles affect how your body uses insulin, and whether exercise can make a difference. It is for people with type 2 diabetes (or normal blood sugar) who are not very active and have been on diabetes medication for a long time.
This study is testing two weight-loss medications: liraglutide alone or combined with orlistat. It is for adults who are overweight or obese and have certain related health conditions like high blood pressure or type 2 diabetes. The goal is to see which treatment works better for long-term weight loss.
Hear when a new Type2 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.